Trials
Search / Trial NCT06424392

Respiratory and Psychological Impact of Elective Surgery of Congenital Lung Malformations

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · May 16, 2024

Trial Information

Current as of February 19, 2025

Recruiting

Keywords

Congenital Lung Malformations Psychological Impact

ClinConnect Summary

This clinical trial is studying the effects of not performing surgery on children with congenital lung malformations (CLMs). The researchers want to see how not having surgery affects parents' anxiety levels when their children are between 6 and 9 years old. They believe that if surgery is avoided, it might lead to less stress for the child and the family, even though there is still a small risk of complications.

To be eligible for this trial, children must be part of the MALFPULM cohort and have had at least one follow-up visit between the ages of 0 and 2. Their parents must also agree to participate. The trial is currently looking for participants, and both children and their parents will be involved in the study. Families can expect to share their experiences and feelings about parenting a child with a congenital lung issue over several years, which will help researchers understand the broader impact of these conditions on family life.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Child of the MALFPULM cohort, with their parents
  • At least one follow-up visit between 0 and 2 years of age (n= 414 eligible children)
  • Non-opposition of the family
  • Exclusion Criteria:
  • Child with CLM, but not included in MALFPULM
  • Parents who participated in MALPULM, but with prenatal fetal death, or neonatal death.

Trial Officials

Christophe DELACOURT

Principal Investigator

Assistance Publique - Hôpitaux de Paris

About Assistance Publique Hôpitaux De Paris

Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.

Locations

Paris, , France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0